Vasoprotective effects hypotensive therapy in patients with coronary heart disease combined with chronic kidney disease stage 2-3 after coronary stenting

MLA

M V Yakovleva, et al. “Vasoprotective Effects Hypotensive Therapy in Patients with Coronary Heart Disease Combined with Chronic Kidney Disease Stage 2-3 after Coronary Stenting.” Kardiologiia, vol. 61, Aug. 2021, pp. 14–22. EBSCOhost, https://doi.org/10.18087/cardio.2021.8.n1525.

APA

M V Yakovleva, E V Gavriljuk, N N Pribylova, T A Barbashina, C A Pribylov, G S Mal, & V S Pribylov. (2021). Vasoprotective effects hypotensive therapy in patients with coronary heart disease combined with chronic kidney disease stage 2-3 after coronary stenting. Kardiologiia, 61, 14–22. https://doi.org/10.18087/cardio.2021.8.n1525

Chicago

M V Yakovleva, E V Gavriljuk, N N Pribylova, T A Barbashina, C A Pribylov, G S Mal, and V S Pribylov. 2021. “Vasoprotective Effects Hypotensive Therapy in Patients with Coronary Heart Disease Combined with Chronic Kidney Disease Stage 2-3 after Coronary Stenting.” Kardiologiia 61 (August): 14–22. doi:10.18087/cardio.2021.8.n1525.